Connect your AI

LENSAR, Inc. LNSR Proceeds from disposition of marketable securities and other investments

Proceeds from disposition of marketable securities and other investments at other companies

Johnson & JohnsonJNJ

$209M-4.1%

MedtronicMDT

——

Other financials

Income statement

Revenue$13.4M-5.2%

Gross profit$6.4M-10.4%

Operating income$2.2M+139%

Net income$36.3M+233%

EPS (diluted)$0.00+100%

Balance sheet

Cash & equivalents$12.5M-36.1%

Total debt$7.6M+206%

Total equity$10.8M+149%

Total assets$66.2M-9.2%

Cash flow

Operating cash flow-$4.3M+38.4%

CapEx$77.0K-31.9%

Free cash flow-—

Valuation

Market cap$70.13M-53.1%

Enterprise value$65.21M-54.9%

P/E2.4×—

P/S1.2×-1.3×

Profitability

Gross margin45.7%-2.1pp

Operating margin-28.7%+7.3pp

Net margin50.9%+30.7pp

FCF margin-26.6%—

Returns & leverage

Return on equity-164%-235pp

Debt / equity0.7×—

Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s proceeds from disposition of marketable securities and other investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LENSAR, Inc.'s proceeds from disposition of marketable securities and other investments?: LENSAR, Inc. (LNSR) reported proceeds from disposition of marketable securities and other investments of $4M in Q1 2026.
How has LENSAR, Inc.'s proceeds from disposition of marketable securities and other investments changed year-over-year?: LENSAR, Inc.'s proceeds from disposition of marketable securities and other investments increased by 14.3% year-over-year, from $3.5M to $4M.